Actuate Therapeutics, Inc. (ACTU)

CIK 1652935 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Actuate Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 2, 202640001193125-26-443732
Oct 30, 20268-K0001683168-26-008193
Oct 30, 2026SCHEDULE 13G0001753926-26-002033
Oct 30, 202640001791917-26-000006
Oct 30, 202640001697316-26-000014
Oct 29, 202640001683168-26-008147
Oct 28, 20268-K0001683168-26-008143
Oct 28, 2026424B50001683168-26-008122
Oct 26, 2026EFFECT9999999995-26-003345
Oct 19, 2026S-1/A0001683168-26-007941
Oct 14, 2026S-1/A0001683168-26-007832
Oct 8, 2026FWP0001683168-26-007710
Oct 6, 2026S-10001683168-26-007661
Aug 14, 202640001683168-26-006493
Aug 14, 202610-Q0001683168-26-006472
Jul 17, 20268-K0001683168-26-005616
May 22, 202640001683168-26-004260
May 22, 202640001683168-26-004257
May 22, 202640001683168-26-004255
May 22, 202640001683168-26-004251
May 22, 20268-K0001683168-26-004268
May 22, 202640001683168-26-004245
May 22, 202640001683168-26-004243
May 22, 202640001683168-26-004241
May 14, 2026S-80001683168-26-003915